首页 > 组织芯片 > > RLN1041a
tissue microarray-RLN1041a
  • 点数:
    104
    例数:
    104
    点样直径(mm):
    1
    厚度(µm):
    5
    行数:
    8
    列数:
    13
    组织阵列类型:
    FFPE
    种属:
    Human
RLN1041a
加入收藏

描述: 肺癌及正常组织组合芯片,附病理分级、TNM、临床分期,104例/104点,替代RLN1041

详情: 肺癌及正常组织组合微阵列芯片,包含52例鳞状细胞癌,13例腺癌,10例细支气管肺泡癌,9例腺磷癌,5例大细胞癌,2例不典型类癌,3例小细胞癌,3例神经内分泌癌,3例结核,4例肺组织,一例一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Lung
  • Inflammation(*)
  • Malignant(*)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Normal(*)
  • _ma
组织芯片
RLN1041a
1
2
3
4
5
6
7
8
9
10
11
12
13
A
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
B
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
C
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
D
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
E
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
F
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
G
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
H
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
_ma
RLN1041a
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 53 M Lung Squamous cell carcinoma - T2N0M0 IB Malignant 3*3*3
A2
2 50 M Lung Squamous cell carcinoma 2 T3N1M0 IIIA Malignant *
A3
3 24 M Lung Squamous cell carcinoma 1 T2aN0M0 IB Malignant *
A4
4 68 M Lung Squamous cell carcinoma 1 T2N0M0 IB Malignant *
A5
5 30 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 4.5*4*3
A6
6 50 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 7.5*5*4
A7
7 64 M Lung Squamous cell carcinoma 1 T2N0M0 IB Malignant *
A8
8 64 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 5*4*4
A9
9 69 M Lung Squamous cell carcinoma 2 T2N2M0 IIIA Malignant *
A10
10 60 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
A11
11 68 M Lung Squamous cell carcinoma - T2N2M0 IIIA Malignant *
A12
12 45 M Lung Squamous cell carcinoma 1 T2aN0M0 IB Malignant *
A13
13 61 M Lung Squamous cell carcinoma 1 T2aN0M0 IB Malignant *
B1
14 60 F Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 5*4*4
B2
15 58 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant *
B3
16 61 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
B4
17 48 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant *
B5
18 52 F Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
B6
19 72 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 4*3*3
B7
20 30 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 5*3*3
B8
21 58 M Lung Squamous cell carcinoma 2 T3N1N0 IIIA Malignant 4*4*3
B9
22 59 M Lung Squamous cell carcinoma 2 T2bN0N0 IIA Malignant *
B10
23 64 M Lung Squamous cell carcinoma 2 T2N2M0 IIIA Malignant *
B11
24 59 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
B12
25 47 M Lung Squamous cell carcinoma 2 T2aN0M0 IB Malignant *
B13
26 49 F Lung Squamous cell carcinoma 1 T2N0M0 IB Malignant *
C1
27 57 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant 8*8*7
C2
28 70 M Lung Squamous cell carcinoma 2 T3N0M0 IIB Malignant 5*4*4
C3
29 55 M Lung Squamous cell carcinoma 2 T4N1M0 IIIA Malignant 3*2*1.5
C4
30 56 M Lung Squamous cell carcinoma 2 T3N0M0 IIB Malignant 6.5*5*5
C5
31 67 M Lung Squamous cell carcinoma 2 T2bN0N0 IIA Malignant 4*3.5*3
C6
32 69 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 7*5*4
C7
33 55 M Lung Squamous cell carcinoma 2 T2bN0N0 IIA Malignant 5.5*4*3.5
C8
34 55 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
C9
35 67 M Lung Squamous cell carcinoma 2 T2bN1M0 IIB Malignant 7*6*6
C10
36 63 M Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant 3*2*1.5
C11
37 75 M Lung Squamous cell carcinoma 3 T3N0M0 IIB Malignant *
C12
38 69 M Lung Squamous cell carcinoma 3 T2N1M0 IIB Malignant 4*4*3
C13
39 53 F Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant *
D1
40 56 M Lung Squamous cell carcinoma 2 T2aN0M0 IB Malignant *
D2
41 66 M Lung Squamous cell carcinoma 2 T2bN0M0 IIA Malignant 4.0*4.0*2.5
D3
42 50 F Lung Squamous cell carcinoma 2 T2aN0M0 IB Malignant *
D4
43 56 M Lung Squamous cell carcinoma 3 T2aN2M0 IIIA Malignant *
D5
44 65 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 5*4*3.5
D6
45 67 M Lung Squamous cell carcinoma 2 T1N0M0 IA Malignant *
D7
46 60 M Lung Squamous cell carcinoma 2 T2bN0N0 IIA Malignant 6*5*5
D8
47 59 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
D9
48 63 M Lung Squamous cell carcinoma 3 T3N1M0 IIIA Malignant *
D10
49 62 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
D11
50 64 F Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant *
D12
51 46 F Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
D13
52 71 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
E1
53 72 M Lung Adenocarcinoma 2 T3N0M0 IIB Malignant 6
E2
54 49 F Lung Adenocarcinoma 3 T2N0M0 IB Malignant *
E3
55 63 F Lung Adenocarcinoma 3 T2bN0N0 IIA Malignant *
E4
56 70 M Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant 7
E5
57 43 F Lung Adenocarcinoma 3 T2N0M0 IB Malignant 3.5*3*2.5
E6
58 37 F Lung Adenocarcinoma 3 T2N0M0 IB Malignant *
E7
59 42 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant *
E8
60 59 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant *
E9
61 48 M Lung Adenocarcinoma 3 T2N1M0 IIB Malignant *
E10
62 62 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant 4.5*4.0*3
E11
63 65 M Lung Adenocarcinoma 3 T2bN0N0 IIA Malignant 7.5*5.0*4
E12
64 48 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant *
E13
65 70 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6.5*4.5*4
F1
66 F 74 Lung Bronchioloalveolar carcinoma * * * Malignant *
F2
67 M 58 Lung Bronchioloalveolar carcinoma * * * Malignant *
F3
68 M 74 Lung Bronchioloalveolar carcinoma * * * Malignant *
F4
69 F 56 Lung Bronchioloalveolar carcinoma * * * Malignant *
F5
70 F 74 Lung Bronchioloalveolar carcinoma * * * Malignant *
F6
71 F 55 Lung Bronchioloalveolar carcinoma * * * Malignant *
F7
72 M 49 Lung Bronchioloalveolar carcinoma * * * Malignant *
F8
73 M 50 Lung Bronchioloalveolar carcinoma * * * Malignant *
F9
74 M 51 Lung Bronchioloalveolar carcinoma * * * Malignant *
F10
75 F 56 Lung Bronchioloalveolar carcinoma * * * Malignant *
F11
76 F 58 Lung Adenosquamous carcinoma * T2bN1M0 IIB Malignant 6.5*5.0*4.5
F12
77 F 55 Lung Adenosquamous carcinoma * T2N1M0 IIB Malignant *
F13
78 M 65 Lung Adenosquamous carcinoma * T2N0M0 IB Malignant *
G1
79 M 50 Lung Adenosquamous carcinoma * T2N1M0 IIB Malignant *
G2
80 M 46 Lung Adenosquamous carcinoma * T2N0M0 IB Malignant *
G3
81 F 63 Lung Adenosquamous carcinoma * T2N0M0 IB Malignant *
G4
82 M 68 Lung Adenosquamous carcinoma * T2N0M0 IB Malignant *
G5
83 M 64 Lung Adenosquamous carcinoma * T2aN0M0 IB Malignant *
G6
84 F 65 Lung Adenosquamous carcinoma * T2bN2M0 IIIA Malignant *
G7
85 M 64 Lung Large cell carcinoma * * * Malignant *
G8
86 M 60 Lung Large cell carcinoma * * * Malignant *
G9
87 M 60 Lung Large cell carcinoma * * * Malignant *
G10
88 M 69 Lung Large cell carcinoma * * * Malignant *
G11
89 F 60 Lung Large cell carcinoma * * * Malignant *
G12
90 36 F Lung Atypical carcinoid * T2aN0M0 IB Malignant *
G13
91 49 M Lung Atypical carcinoid * T4N2M0 IIIB Malignant *
H1
92 52 M Lung Small cell carcinoma * T2aN0M0 IB Malignant 4
H2
93 61 M Lung Small cell carcinoma * T2N0M0 IB Malignant 3.5*3*0.7
H3
94 52 M Lung Small cell carcinoma * * * Malignant 4*5
H4
95 63 M Lung Neuroendocrine carcinoma * * * Malignant *
H5
96 82 M Lung Neuroendocrine carcinoma * * * Malignant *
H6
97 53 M Lung Neuroendocrine carcinoma * * * Malignant *
H7
98 54 M Lung Pulmonary tuberculosis * * * Inflammation *
H8
99 63 F Lung Pulmonary tuberculosis * * * Inflammation *
H9
100 50 F Lung Pulmonary tuberculosis * * * Inflammation *
H10
101 25 F Lung Lung tissue * * * Normal *
H11
102 19 M Lung Lung tissue * * * Normal *
H12
103 40 F Lung Lung tissue * * * Normal *
H13
104 47 M Lung Lung tissue * * * Normal *
_marker_
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们
0.082803s